Definitely BS, you're right...the MM manipulation is a
Definitely BS, you're right...the MM manipulation is a given for us. When I last looked there was a sell wall at .3090 and a false support/spoof order at .2925. I had ChatGPT look at the level II and got this:
Potential Sell Wall at $0.3090 (ETRF)
ETRF has 19,150 shares listed at $0.3090, noticeably more than any other ask level.
That’s about 4x the size of the top ask at $0.2950.
ETRF also appears on the bid side at $0.2904 (10,000 shares), which could indicate:
Market-making behavior (widening the spread to capture profits)
Or more likely in CYDY’s case, algorithmic short selling, where:
Large asks act as a lid to cap price movement.
Bid activity is used to create an illusion of support or to soak up weak hands.
Conclusion: That’s a classic setup for a "soft ceiling" or sell wall to discourage buyers from pushing past a psychologically significant number (e.g. $0.31).
False Support at $0.2925 (GTSM)
GTSM is showing 25,100 shares at $0.2925, the best bid.
That’s much larger than the next several bid levels — suggesting “support.”
However, GTSM is known to sometimes pull orders rapidly (a hallmark of spoofing or passive bid-posting).
If the bid is pulled during selling pressure, it reveals there was no intention to buy — just to give the illusion of depth.
Conclusion: This could be false support, especially if:
The bid disappears on down-ticks.
It’s repeatedly reloaded just to anchor the price perception.
Strategic Interpretation:
This combination — heavy resistance above and illusory support below — is often used to:
Maintain a tight range (here, ~$0.292–0.295)
Exhaust intraday buyers
Induce weak-handed selling
This can be particularly relevant if someone is shorting against warrants or accumulating quietly at lower levels.
7
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
An Unexpected Turn in the Drug Discovery Arena It's not every day that you see a historic French pharma powerhouse and a cutting-edge Chinese tech firm join forces. On one side, we've got Laboratoires Pierre Fabre, steeped in the history and nitty-gritty of clinical drug development. On the other, we’ve got XtalPi Holdings Limited (2228.HK), bringing their high-tech AI...
Continue Reading
The Need for Unity in a Warming World Some folks out there might be scratching their heads, wondering what sparks are flying between China, Europe, and Africa this time. Well, during the 2026 China-Europe-Africa Green Energy Development Forum held in sunny Zhejiang, the theme was loud and clear: We've got to deepen green partnerships to build a zero-carbon future. They're...
Continue Reading
A High-Tech Twist on Traditional Culture You ever walk into a room and see a robot perform kung fu? I'll admit, it caught me off guard at first. But that's exactly what happened at the "Enduring Heritage, Harmonious Asia-Pacific" special exhibition in Shenzhen. With all the usual high-ranking execs and cultural bigwigs there, nobody expected a showcase where Wing Chun...
Continue Reading
Facchin Joins Reactive Technologies: Power Play or Predictable Move? Let me tell you, the energy sector ain’t for the faint-hearted—especially when you’re talking grid stability. Reactive Technologies just tossed an ace on the table, appointing Claudio Facchin as the new Board Chairman. If you've been around the block, you might recognize Facchin's name from his...
Continue Reading
A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...
Continue Reading
Rosti Bets on Expansion with Alvi Buyout Rosti Group just rolled the dice big by swallowing Alvi Group, marking another bold move in the ever-swinging industrial and medical device manufacturing rodeo. Suddenly, we’re talking about a company with roughly 3,000 employees on its roster and a neat EUR 450 million in combined revenue. Don't overlook the power play...
Continue Reading
Onodrim Industries' Bold Bid to Reshape European Security Right out of the gate, Onodrim Industries is thundering onto the scene with a hefty $300 million Series A round to flex its muscles across Europe's defence and industrial sectors. This ain't your run-of-the-mill startup story. This is about flexing hard-earned capital to snap up established players and inject a...
Continue Reading
Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...
Continue Reading
Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...
Continue Reading
Agilix Labs' Landmark Leap with AWS Just when you think you've got the grip on global education dynamics, a new wave hits your shores, this time courtesy of Agilix Labs and AWS. Agilix Labs snagged a grant from Amazon Web Services, carving a path that blends AI with educational equity in Sierra Leone. Now, if that doesn’t prick up investor ears or yank a few...
Continue Reading
Top 5 Most Recently Viewed Articles
Safe & Green Holdings Corp. Welcomes New COO, Jim Pendergast Safe & Green Holdings Corp. (NASDAQ: SGBX) is excited to announce the appointment of Jim Pendergast as the new Chief Operating Officer. This pivotal addition to the leadership team marks an important step forward in the company's vision of driving innovation and excellence in modular construction. Profile of Jim...
Continue Reading
Understanding Rosen Law Firm's Investigation for Investors Rosen Law Firm is central to the ongoing concern surrounding mutual funds from Western Asset Management Company. We're here to guide investors in understanding their rights and possible claims associated with these investments. The Allegations Against Western Asset Management Company Recent allegations indicate...
Continue Reading
Projected Growth of the US Electronic Warfare Market The US Electronic Warfare market is on track to achieve a remarkable USD 8.99 billion by 2028, following a growth pattern from USD 6.45 billion in 2024, showcasing a compound annual growth rate (CAGR) of 8.6% during this period. The United States is globally acknowledged as a leading manufacturer and user of electronic...
Continue Reading
Ping An Unveils Innovative Self-Operated Hospital in Shenzhen PING AN is excited to announce the opening of its latest self-operated hospital in Shenzhen, named Shenzhen Beiyi Rehabilitation Hospital. This facility represents a significant milestone in health and senior care, catering to the growing needs of residents in the Greater Bay Area. Commitment to Comprehensive...
Continue Reading
PARRIS Law Firm Achieves Major Victory in Consumer Lawsuit The PARRIS Law Firm has recently celebrated a significant win for consumers in a landmark lawsuit against Southern California Edison Company. This case, referencing the Wellman v. Southern California Edison Company, has captured media attention, notably from The Daily Journal, showcasing the firm’s commitment to...
Continue Reading